Your browser doesn't support javascript.
loading
Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Guérin-Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-Up From a Phase 3 Trial.
Narayan, Vikram M; Boorjian, Stephen A; Alemozaffar, Mehrdad; Konety, Badrinath R; Shore, Neal D; Gomella, Leonard G; Kamat, Ashish M; Bivalacqua, Trinity J; Montgomery, Jeffrey S; Lerner, Seth P; Busby, Joseph E; Poch, Michael; Crispen, Paul L; Steinberg, Gary D; Schuckman, Anne K; Downs, Tracy M; Mashni, Joseph; Lane, Brian R; Guzzo, Thomas J; Bratslavsky, Gennady; Karsh, Lawrence I; Woods, Michael E; Brown, Gordon; Canter, Daniel; Luchey, Adam; Lotan, Yair; Inman, Brant A; Williams, Michael B; Cookson, Michael S; Chang, Sam S; Sankin, Alexander I; O'Donnell, Michael A; Sawutz, David; Philipson, Richard; Parker, Nigel R; Yla-Herttuala, Seppo; Rehm, Dorte; Jakobsen, Jørn S; Juul, Kristian; Dinney, Colin P N.
Affiliation
  • Narayan VM; Department of Urology, Emory University School of Medicine, Atlanta, Georgia.
  • Boorjian SA; Department of Urology, Mayo Clinic, Rochester, Minnesota.
  • Alemozaffar M; Department of Urology, Southern California Permanente Medical Group, Los Angeles, California.
  • Konety BR; Department of Urology, University of Minnesota and Allina Health Cancer Institute, Minneapolis, Minnesota.
  • Shore ND; Carolina Urologic Research Center, Myrtle Beach, South Carolina.
  • Gomella LG; Department of Urology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Kamat AM; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Bivalacqua TJ; Division of Urology, Department of Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
  • Montgomery JS; Department of Urology, University of Michigan, Ann Arbor, Michigan.
  • Lerner SP; Scott Department of Urology, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas.
  • Busby JE; Cancer Centers of the Carolinas, Greenville Hospital System, Greenville, South Carolina.
  • Poch M; Department of GU Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida.
  • Crispen PL; Department of Urology, University of Florida, Gainesville, Florida.
  • Steinberg GD; Department of Urology, Rush University, Chicago, Illinois.
  • Schuckman AK; USC Institute of Urology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California.
  • Downs TM; Department of Urology, University of Virginia, Charlottesville, Virginia.
  • Mashni J; Banner MD Anderson Cancer Center, Gilbert, Arizona.
  • Lane BR; Division of Urology, Spectrum Health, Michigan State University College of Human Medicine, Grand Rapids, Michigan.
  • Guzzo TJ; Division of Urology, Department of Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
  • Bratslavsky G; Department of Urology, SUNY Upstate Medical University, Syracuse, New York.
  • Karsh LI; The Urology Center of Colorado, Denver, Colorado.
  • Woods ME; Department of Urology, Loyola University Medical Center, Maywood, Illinois.
  • Brown G; New Jersey Urology, Bloomfield, New Jersey.
  • Canter D; Georgia Urology, Atlanta, Georgia.
  • Luchey A; West Virginia University Cancer Institute, Morgantown, West Virginia.
  • Lotan Y; Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Inman BA; Division of Urology, Department of Surgery, Western University, London, Ontario, Canada.
  • Williams MB; Urology of Virginia, Virginia Beach, Virginia.
  • Cookson MS; Department of Urology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
  • Chang SS; Department of Urology, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Sankin AI; Department of Urology, Montefiore Medical Center, Bronx, New York.
  • O'Donnell MA; Department of Urology, University of Iowa, Iowa City, Iowa.
  • Sawutz D; FKD Therapies Oy, Kuopio, Finland.
  • Philipson R; Calliditas Therapeutics, Stockholm, Sweden.
  • Parker NR; AI Virtanen Institute University of Eastern Finland and Science Service Center and Gene Therapy Unit, Kuopio, Finland.
  • Yla-Herttuala S; AI Virtanen Institute University of Eastern Finland and Science Service Center and Gene Therapy Unit, Kuopio, Finland.
  • Rehm D; Ferring Pharmaceuticals A/S, Copenhagen, Denmark.
  • Jakobsen JS; Ferring Pharmaceuticals A/S, Copenhagen, Denmark.
  • Juul K; Ferring Pharmaceuticals A/S, Copenhagen, Denmark.
  • Dinney CPN; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas.
J Urol ; 212(1): 74-86, 2024 Jul.
Article in En | MEDLINE | ID: mdl-38704840
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Urinary Bladder Neoplasms / BCG Vaccine Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: J Urol Year: 2024 Type: Article Affiliation country: Georgia
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Urinary Bladder Neoplasms / BCG Vaccine Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: J Urol Year: 2024 Type: Article Affiliation country: Georgia